JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (2): 52-55.doi: 10.6040/j.issn.1671-7554.0.2014.235

Previous Articles     Next Articles

Clinical study on the association between metabolic syndrome and P wave dispersion

ZHANG Fenglei, ZHENG Man, ZHANG Qi, GU Lei, XU Xinsheng   

  1. Department of Cardiology, Dongying People's Hospital, Dongying 257091, Shandong, China
  • Received:2014-04-17 Published:2015-02-10

PDF (PC)

188

Abstract: Objective To investigate the effect of metabolic syndrome on P wave dispersion (Pd), in order to reveal its proarrhythmic effect. Methods A total of 86 patients with metabolic syndrome and 102 controls were enrolled in the study. The maximum P wave duration (P max) and minimum P wave duration (P min) were measured with 12-lead synchronous surface electrocardiogram (ECG), and Pd was calculated using P max minus P min. Results Compared with the controls, patients had significantly higher value of Pd (47.31±12.18 vs 33.08±11.04, P=0.001). However, there was no much difference in P max and P min between the two groups (P>0.05). Correlation analyses revealed positive correlation between Pd and body mass index (BMI, P=0.001), total cholesterol (TC, P=0.038), triglyceride (TG, P=0.001), apolipoprotein B (Apo B, P=0.027), systolic blood pressure (SBP, P=0.036) and diastolic blood pressure (DBP, P=0.015). Multiple linear regression analysis indicated distinct association between BMI and Pd (P=0.001). Conclusion BMI is an independent influencing factor of Pd. Controlling metabolic syndrome and BMI will provide a new approach for the prevention and treatment of arrhythmia, especially atrial fibrillation.

Key words: P wave dispersion, Metabolic syndrome, Atrial fibrillation, Electrocardiogram

CLC Number: 

  • R543.3
[1] Watanabe H, Tanabe N, Watanabe T, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study[J]. Circulation, 2008, 117(10):1255-1260.
[2] Başar N, Malçok Gürel O, Ozcan F, et al. Diagnostic accuracy of P-wave dispersion in prediction of maintenance of sinus rhythm after external cardioversion of atrial fibrillation[J]. Anadolu Kardiyol Derg, 2011, 11(1):34-38.
[3] Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease:a meta-analysis[J]. Am J Med, 2006, 119(10):812-819.
[4] Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis[J]. J Am Coll Cardiol, 2010, 56(14):1113-1132.
[5] Nguyen NT, Nguyen XM, Wooldridge JB, et al. Association of obesity with risk of coronary heart disease: findings from the national health and nutrition examination survey, 1999-2006[J]. Surg Obes Relat Dis, 2010, 6(5):465-469.
[6] Menezes AR, Lavie CJ, Dinicolantonio JJ, et al. Cardiometabolic risk factors and atrial fibrillation[J]. Rev Cardiovasc Med, 2013, 14(2-4):73-81.
[7] Nguyen JT, Benditt DG. Atrial fibrillation susceptibility in metabolic syndrome: simply the sum of its parts[J] .Circulation, 2008, 117(10):1249-1251.
[8] Bissinger A, Grycewicz T, Grabowicz W, et al. The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation[J]. Arch Med Sci, 2011, 7(5):806-812.
[9] Tadic M, Ivanovic B, Cuspidi C. What do we currently know about metabolic syndrome and atrial fibrillation[J]. Clin Cardiol, 2013, 36(11): 654-662.
[10] Dentali F, Romualdi E, Ageno W. The metabolic syndrome and the risk of thrombosis[J]. Haematologica, 2007, 92(9): 297-299.
[11] Dilaveris P, Batchvarov V, Gialafos J, et al. Comparison of different methods for manual P wave duration measurement in 12-lead electrocardiograms[J]. Pacing Clin Electrophysiol, 1999, 22(10):1532-1538.
[12] Altieri PI, Figueroa Y, Banchs HL, et al. Higher incidence of atrial fibrillation in the metabolic syndrome: a hispanic population study[J]. Bol Asoc Med P R, 2011, 103(4):24-27.
[13] Hung CL, Chao TF, Lai YH, et al. The relationship among atrium electromechanical interval, insulin resistance, and metabolic syndrome[J]. Can J Cardiol, 2013, 29(10):1263-1268.
[14] Huxley RR, Misialek JR, Agarwal SK, et al. Physical activity, obesity, weight change and risk of atrial fibrillation: The atherosclerosis risk in communities (ARIC) study[J]. Circ Arrhythm Electrophysiol, 2014,7(4): 620-625. doi: 10.1161/CIRCEP.113.001244. Epub 2014 Jun 6.
[15] Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the danish diet, cancer, and health study[J]. Am J Med, 2005, 118(5):489-495.
[16] Tsang TS, Barnes ME, Miyasaka Y, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years[J]. Eur Heart J, 2008, 29(18): 2227-2233.
[17] Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity[J]. Physiol Rev, 2008, 88(2):389-419.
[1] HU Yanwen, WANG Zhiyuan, YU Wanjiang, ZHAO Huichen, HAN Heli, XU Zhipeng, MA Hong, ZHANG Yuchao, LIU Yuantao. Correlation of fat distribution with metabolic syndrome and glucose metabolism in 52 obese patients [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 101-106.
[2] SUN Yuanying, YANG Yachao, QU Mingling, CHEN Yanmin, LI Min, WANG Shukang, XUE Fuzhong, LIU Yunxia. A prediction model for metabolic syndrome risk: a study based on the health management cohort [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 87-92.
[3] WEI Jinqiu, ZHANG Yujiao, LI Zhan, WANG Ximin, CHEN Linlin, DU Juanjuan, ZHANG Yong, XIE Xinxing, HOU Yinglong. Effects of GCH1 on atrial autonomic nerve remodeling by regulating tetrahydrobiopterin in A-TP canines [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 8-12.
[4] YU Zhenzhen, CHEN Hui, YANG Xiaoyun, LÜ Ming. Correlation between hyperuricemi, Helicobacter pylori infection and metabolic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 76-80.
[5] XU Yibo, JI Xiaokang, LI Xiangyi, SHEN Zhenwei, XUE Fuzhong. Analysis on the relationship between urine pH and metabolic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 82-85.
[6] XIAO Juan, CHEN Qicai, ZHANG Pengpeng, CHEN Lili, CHEN Xiaoxiao, WANG Shumei. Association between serum alanine transaminase with metabolic syndrome and its components based on a longitudinal health check-up study in Dongying City, China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(1): 86-91.
[7] ZHANG Kai, LIANG Fei, HAN Bo, MA Xiaochun, ZHU Xiaolong, ZHANG Jun, ZHANG Tao, ZOU Chengwei. Radiofrequency modified maze Ⅲ plus ganglionic plexus ablation vs radiofrequency modified maze Ⅲ alone in the treatment of atrial fibrillation with rheumatic mitral lesion [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(5): 66-70.
[8] LI Man, ZHONG Jingquan, YUE Xin, ZHU Qing, ZHENG Zhaotong, RONG Bing, YI Shaolei, XIE Fei, ZHANG Yun. Effect of different circumferential pulmonary vein ablation endpoints on prognosis of atrial fibrillation patients:bidirectional block between pulmonary veins and left atrium [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 62-68.
[9] ZHANG Lingli, ZHOU Ying, LI Xiaohe, LI Hui, ZHONG Ming, ZHANG Wei. Myocardial MMPs and TIMPs mRNA expressions in Chinese population with atrial fibrillation: a Meta-analysis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(1): 47-53.
[10] JIN Chengwei, LI Kui, ZHAO Jing, YUE Xin, SHANG Yuanyuan, HAN Lu, ZHANG Yun, ZHANG Wei, MA Xiao, ZHONG Ming. Relationship between the mRNA expression of adipose triglyceride lipase in peripheral blood mononuclear cells and metabolic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 39-42.
[11] LI Cong, WANG Jianchun, ZHAO Yong, ZOU Chengwei, SUN Hui, ZHANG Qing. Association between calcineurin-nuclear factor of activated T cell pathway and atrial fibrillation in patients with valvular heart disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 47-51.
[12] HAN Bo1,2, WANG Jianchun2, ZHANG Tao2, ZHU Xiaolong2, LI Cong2, WANG Zhengjun2, ZHAO Yong2, ZOU Chengwei2. Expression of calpain-2 in human left atrium in rheumatic atrial fibrillation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 93-96.
[13] LIU Congcong1, ZHU Yun2, SONG Cuiling3, LIU Ping4. Relationship between metabolic syndrome and serum bilirubin in asymptomatic population of Jinan, China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 101-105.
[14] JIA Tang-hong1， HOU Ting-cheng1， XIE Zhong-yuan1， DOU Ke-hong1， ZHANG Ji2， BIAN Xue-feng2， SHI Yan-shen3， NIU Ji-lun4， YANG Hua5. Epidemiologic survey of metabolic syndrome and its related risk  factors in Jinan community population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 100-106.
[15] LIU Xiao-jun, ZHONG Jing-quan, YI Shao-lei, XU Zhen-xing, LI Man, ZHANG Yun. Electrocardiographic characteristics and radiofrequency catheter ablation of idiopathic ventricular tachycardias or premature ventricular contractions originating from the two non-classical sites [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 42-46.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd